Fred Hutchinson Cancer Research Center

Nektar Therapeutics acknowledged that changes were coming when discussing the failure of its lead candidate bempegaldesleukin (bempeg) in combination with Bristol Myers Squibb Company ’s Opdivo (niv

Many biopharma companies have targeted KRAS mutations in the fight against cancer, most with little success, but bicoastal US biotech Affini-T Therapeutics Inc. thinks it will succeed in treating soli

ElevateBio, LLC was conceived in 2018 as a central hub for both cell and gene therapy R&D and manufacturing that could meet the needs of many regenerative medicine start-ups all the way through comme

City of Hope Licenses CTLX-CAR-T Candidate To Chimeric Independent research and treatment center City of Hope National Medical Center said on 21 September that it has licensed intellectual property